Literature DB >> 6219134

Propionibacterium acnes resistance to antibiotics in acne patients.

J J Leyden, K J McGinley, S Cavalieri, G F Webster, O H Mills, A M Kligman.   

Abstract

The minimal inhibitory concentration (MIC) of Propionibacterium acnes in seventy-five acne patients receiving long-term antibiotic therapy demonstrated the emergence of resistant strains. The mean MIC in thirty-three patients receiving long-term tetracycline was four to five times higher than that found in control groups of acne patients not receiving antibiotic therapy and controls free of acne. The average MIC for erythromycin was more than 100 times higher in those receiving long-term antibiotic therapy. In a second group of sixty-two patients, the clinical course and number of P. acnes were correlated with the presence of "resistant strains" defined as P. acnes with a tenfold increase in MIC to tetracycline or erythromycin. Patients with resistant strains had higher counts of P. acnes and clinically were not doing as well as those with sensitive strains.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219134     DOI: 10.1016/s0190-9622(83)70005-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

Review 1.  Acne vulgaris.

Authors:  Guy F Webster
Journal:  BMJ       Date:  2002-08-31

2.  Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.

Authors:  Stefanie Heller; Laurenz Kellenberger; Stuart Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

3.  In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

Authors:  D Chmelar
Journal:  Folia Microbiol (Praha)       Date:  2009-10-14       Impact factor: 2.099

Review 4.  The tetracycline resistome.

Authors:  Maulik Thaker; Peter Spanogiannopoulos; Gerard D Wright
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

Review 5.  Current views on the aetiology, pathogenesis and treatment of acne vulgaris.

Authors:  L Lever; R Marks
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

6.  Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Authors:  J I Ross; E A Eady; J H Cove; C E Jones; A H Ratyal; Y W Miller; S Vyakrnam; W J Cunliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 7.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression.

Authors:  Eugene Jeong; Ji Won Hong; Jung Ah Min; Dong Won Lee; Mi Yeung Sohn; Weon Ju Lee; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

9.  Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.

Authors:  Sewon Kang; Soyun Cho; Jin Ho Chung; Craig Hammerberg; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 10.  Topical antibacterial therapy for acne vulgaris.

Authors:  Brigitte Dreno
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.